Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Number of holders
-
271
-
Total 13F shares, excl. options
-
104,802,748
-
Shares change
-
-1,395,933
-
Total reported value, excl. options
-
$5,076,619,614
-
Value change
-
-$48,250,542
-
Put/Call ratio
-
33%
-
Number of buys
-
144
-
Number of sells
-
105
-
Price
-
$48.45
Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q3 2022
As of 30 Sep 2022 CYTOKINETICS INC - COMMON STOCK (CYTK) had 271 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 104,802,748 shares of stock of the company.
Largest 10 holders included BlackRock Inc., FMR LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, LORD, ABBETT & CO. LLC, Polar Capital Holdings Plc, RTW INVESTMENTS, LP, PFM Health Sciences, LP, and PICTET ASSET MANAGEMENT SA.
This table shows 271 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.